Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Well Now it is clear - I think

<HTC has now indicated that it will move to reopen already settled claim construction
issues. Otteson Decl., ¶ 10; Exh. D. Pending HTC’s forthcoming claim construction motion
(which TPL will oppose), there is no “final claim construction ruling” – which is a triggering event for final contentions under the Case Management Order.>

Opty

Share
New Message
Please login to post a reply